Stay updated on Spearhead 1 Study in Advanced Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Spearhead 1 Study in Advanced Sarcomas Clinical Trial page.

Latest updates to the Spearhead 1 Study in Advanced Sarcomas Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedDifference0.3%
- Check26 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check33 days agoNo Change Detected
- Check40 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check47 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check61 days agoChange DetectedThe study has transitioned to 'Active, not recruiting' status, with significant updates on response rates, adverse events, and survival metrics for the ongoing trial of afamitresgene autoleucel in advanced synovial sarcoma and myxoid round cell liposarcoma, while several previous details including contact information and recruitment status have been removed.SummaryDifference66%
- Check69 days agoChange DetectedThe website has updated its contact information and added several new principal investigators, while also removing previous entries for the same roles, indicating a significant refresh of personnel and contact details.SummaryDifference28%
Stay in the know with updates to Spearhead 1 Study in Advanced Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Spearhead 1 Study in Advanced Sarcomas Clinical Trial page.